These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 33757530)

  • 1. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
    Li W; Wang B; Tan M; Song X; Xie S; Wang C
    Respir Res; 2022 Nov; 23(1):321. PubMed ID: 36403054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
    Huang YJ; Boushey HA
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease.
    Wu Y; Luo Z; Liu C
    Life Sci; 2021 Jan; 265():118738. PubMed ID: 33181175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA; Knutson KA; Gould TJ; Hodgson SW; Isaacson RE; Reilly CS; Wendt CH
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
    Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
    Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
    J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.
    Ramsheh MY; Haldar K; Esteve-Codina A; Purser LF; Richardson M; Müller-Quernheim J; Greulich T; Nowinski A; Barta I; Stendardo M; Boschetto P; Korzybski D; Prasse A; Parr DG; Hohlfeld JM; Döme B; Welte T; Heath S; Gut I; Morrissey JA; Ziegler-Heitbrock L; Barer MR; Singh D; Brightling CE
    Lancet Microbe; 2021 Jul; 2(7):e300-e310. PubMed ID: 35544166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study.
    Xue Q; Xie Y; He Y; Yu Y; Fang G; Yu W; Wu J; Li J; Zhao L; Deng X; Li R; Wang F; Zheng Y; Gao Z
    Sci Rep; 2023 Apr; 13(1):5715. PubMed ID: 37029178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
    Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ;
    Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the correlation between BMI and respiratory tract microbiota in acute exacerbation of COPD.
    Cao Y; Chen X; Shu L; Shi L; Wu M; Wang X; Deng K; Wei J; Yan J; Feng G
    Front Cell Infect Microbiol; 2023; 13():1161203. PubMed ID: 37180432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.
    Millares L; Pascual S; Montón C; García-Núñez M; Lalmolda C; Faner R; Casadevall C; Setó L; Capilla S; Moreno A; Castro-Acosta AA; Alvarez-Martinez CJ; Sibila O; Peces-Barba G; Cosio BG; Agustí A; Gea J; Monsó E
    BMC Pulm Med; 2019 Jun; 19(1):112. PubMed ID: 31234826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
    Su L; Qiao Y; Luo J; Huang R; Xiao Y
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.
    Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E
    J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Metagenomics of the Bronchial Microbiome in COPD.
    Millares L; Pérez-Brocal V; Ferrari R; Gallego M; Pomares X; García-Núñez M; Montón C; Capilla S; Monsó E; Moya A
    PLoS One; 2015; 10(12):e0144448. PubMed ID: 26632844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.